5 completed, 2 unknown, 1 recruiting. 5 Phase 4, 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 3, Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
Follow xuezhikang: new trials by email Literature Review of xuezhikang trials Research Report on xuezhikang
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes Xuezhikang, Atorvastatin - Prediabetic State (IGT) | Phase 4 | Recruiting | Beijing Tsinghua Chang Gung Hospital | 398 | 2024-12-31 | 2025-04-03 |
| Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes Xuezhikang Capsule, Atorvastatin Calcium Tablets - Metabolism Disorder, Lipid, Metabolism Disorder, Glucose | Phase 4 | Completed | Heart Health Research Center | 392 | 2022-08-02 | 2024-05-21 |
| The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardized Statin Red yeast rice and atorvastatin, Atorvastatin alone - Dyslipidemia, Atherosclerosis | Phase 3 | Unknown | Wenzhou Medical University | 240 | 2015-11-01 | 2024-08-06 |
| Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers XueZhiKang, Lovastatin - Lipid Metabolism Disorder | Phase 1 | Completed | Luye Pharma Group Ltd. | 20 | 2015-11-01 | 2016-12-05 |
| Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive Patients Xuezhikang, Atorvastatin, Lifestyle modification - Hypertension | Phase 4 | Unknown | Chinese Academy of Medical Sciences, Fuwai Hospital | 300 | 2013-10-01 | 2014-10-02 |
| The Effect of XueZhiKang on Fatigue：Comparing With Simvastatin XueZhiKang, simvastatin - Dyslipidemias | Phase 4 | Completed | Wenzhou Medical University | 60 | 2012-08-01 | 2014-05-19 |
| Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia XueZhiKang (XZK), a botanic product with multiple components, Placebo - Hyperlipidemia | Phase 2 | Completed | Beijing Peking University WBL Biotech Co., Ltd. | 116 | 2011-04-01 | 2014-07-23 |
| A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia Xuezhikang capsule - Dyslipidemia | Phase 4 | Completed | China Academy of Chinese Medical Sciences | 2400 | 2010-03-01 | 2014-02-07 |
Dyslipidemias (4) · Lipid Metabolism Disorders (2) · Prediabetic State (2) · Atherosclerosis (1) · Diabetes Mellitus (1) · Glucose Metabolism Disorders (1) · Hyperlipidemias (1) · Hypertension (1)
Wenzhou Medical University (2) · Beijing Peking University WBL Biotech Co., Ltd. (1) · Beijing Tsinghua Chang Gung Hospital (1) · China Academy of Chinese Medical Sciences (1) · Chinese Academy of Medical Sciences, Fuwai Hospital (1) · Heart Health Research Center (1) · Luye Pharma Group Ltd. (1)
China (6) · United States (2)
Aimin Dang, Doctor (1) · Changsheng Ma, MD (1) · David Capuzzi (1) · Jifei Tang, MD (1) · Kangting Ji, MD (1) · Simon LI, M.D. (1)